Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Aug 21.
Published in final edited form as: Subst Use Addctn J. 2024 May 28;45(4):653–663. doi: 10.1177/29767342241249870

Characterizing the use of healthcare access supports among people who use drugs in Vancouver, Canada, 2017-2020: A cohort study

Kanna Hayashi 1,2, Gabrielle Rabu 1, Zishan Cui 1,3, Sukhpreet Klaire 1,4,5, Fahmida Homayra 6, M-J Milloy 1,7, Bohdan Nosyk 2,6
PMCID: PMC12366755  NIHMSID: NIHMS2092298  PMID: 38804580

Abstract

Background:

For structurally-marginalized populations, including people who use drugs (PWUD), equitable access to healthcare can be achieved through healthcare access supports. However, few studies characterized utilization of formal (e.g., outreach workers, healthcare professionals) and informal (e.g., friends/family) supports. Therefore, we sought to estimate the prevalence of and factors associated with receiving each type of support among PWUD.

Methods:

We used data from two prospective cohort studies of PWUD in Vancouver, Canada in 2017-2020. We constructed separate multivariable generalized linear mixed-effects models to identify factors associated with receiving each of the three types of supports (i.e., healthcare professionals, outreach workers/peer navigators, and informal supports) compared to no supports.

Results:

Of 996 participants, 350 (35.1%) reported receiving supports in the past six months at baseline, through informal supports (6.2%), outreach workers (14.1%) and healthcare professionals (20.9%). In multivariable analyses, HIV positivity, chronic pain and avoiding healthcare due to the past mistreatment were positively associated with receiving supports from each of healthcare professionals and outreach workers. Men were less likely to receive any types of the supports (all p<0.05).

Conclusions:

Utilization of healthcare access supports was relatively low in this sample. However, formal supports appeared to have reached PWUD exhibiting more comorbidities and experiencing discrimination in healthcare. Further efforts to make formal supports more available would benefit PWUD with unmet healthcare needs, particularly men.

Keywords: Health Disparity, Minority and Vulnerable Populations, Health services, Substance-related disorders

INTRODUCTION

People who use drugs (PWUD), especially through intravenous use, have a high burden of disease including infectious diseases such as HIV and hepatitis C virus (HCV) as well as psychiatric conditions and chronic pain.1-4 The high level of medical and psychiatric complexity amongst PWUD contribute to an overall high healthcare need as well as an increased difficulty accessing healthcare services.5 Many PWUD seeking care face stigma and discrimination, difficulties accessing transport, and cost barriers in areas without universal healthcare.6-10 These factors likely contribute to delays in seeking care11 and an increase in emergency room visits in lieu of accessing primary care services.12 It is no surprise that there is high prevalence of unmet healthcare need amongst PWUD. A prior study from Vancouver, Canada found that 25% of 889 community-recruited PWUD reported an unmet healthcare need in 2017-2018.13 Another cross-sectional study from Edmonton, Canada reported a higher prevalence of unmet need for substance use and mental health-related care (82%) among 320 street-involved PWUD who were not accessing any specialty mental health or addiction treatment in 2014.14

Improving access to care to meet the care needs of structurally marginalized groups is a topic of concern in addiction research.3,4,12-14 Multiple models of care have been proposed, including integrated health services that include allied health professionals, such as social workers.3,4 What many of these models do not address is the need for supports to help access their services. Due to significant comorbidity and the effects of substances, many PWUD would benefit from support accessing services, keeping appointments, and completing investigations.4 Support can come in many forms: for some it may be the help of family and friends, for others it may come in a formal form of help from peer navigators and outreach workers, and still others may go directly to their healthcare professionals for this kind of assistance. By definition, peer navigators have lived experience and training consistent with the population they are serving.15 They generally provide social support, role modeling, and outreach services.15,16 Outreach workers are trained individuals who also provide social support and outreach services but do not necessarily have lived experience with the population they serve. Outreach workers and peer navigators have been key to health services reaching priority populations, however, this has mostly been studied in specific disease and situation-targeted cases such as motherhood,4 psychiatric illness,17 incarceration,18,19 homelessness,16 addiction treatment20,21 and chronic illnesses such as HIV.22-25 This disease-specific research approach is mirrored in the services available. For example, the Assertive Community Treatment program (ACT)26 and the Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS)27 teams in Vancouver are both outreach services for people with psychiatric conditions and HIV, respectively. Furthermore, few studies have examined the prevalence and characteristics of PWUD who use supports from outreach workers and peer navigators in real world settings.

In 2017, the Vancouver Coastal Health Authority sought to develop an evidence-based, community directed model of interdisciplinary primary care for the residents of the Downtown Eastside (DTES) of Vancouver, BC.28 The DTES neighbourhood is characterized by high rates of marginalization, substance use and infectious disease.29 This model of care, called the Downtown Eastside Second Generation Strategy (DTES-2GS), included establishing three primary care clinics with integrated care teams in January 2018, improving access to outreach supports, improving cultural competency and trauma informed training for staff and a substantial increase in peer roles.28,30 In light of the implementation of the DTES-2GS, with its focus on peer support work and outreach workers, we sought to determine the prevalence of, and factors associated with the use of different supports accessing healthcare amongst PWUD in Vancouver. We included formal supports such as peer navigators and outreach workers, informal supports such as the help of friends and family as well as the support of healthcare professionals such as nurses, doctors, and social workers in our evaluation.

METHODS

Data Sources and study sample

We used data from the DTES-2GS evaluation study. This study sought to collect information on PWUD’s experiences with healthcare access and non-clinical quality of care, measuring experiences such as perceived discrimination, access and cultural safety.31 The 2GS evaluation study was nested within two ongoing prospective cohort studies of community-recruited PWUD in Vancouver, Canada: The Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS). The VIDUS and ACCESS studies have been previously described in detail.32 In short, VIDUS enrols adult (aged 18 years or older) PWUD who are HIV-seronegative and injected drugs in the month prior to enrolment. ACCESS enrols adult PWUD who are HIV-seropositive. Both cohorts recruit participants through word-of-mouth and street outreach from a frontline office in the DTES. The cohorts are harmonized and administer the same questionnaires by trained interviewers every six months, and nurses draw blood for HIV and HCV serology during the visit. Recruitment for the 2GS evaluation study was described in detail elsewhere.13 In brief, VIDUS and ACCESS participants who completed an in-person study follow-up visit between December 2017 and November 2018 were invited to participate in the 2GS evaluation study as a supplement to the parent cohorts through a convenience sampling approach until 1,000 participants were enrolled in the 2GS evaluation study. The 2GS study participants were asked to complete both the parent cohorts and 2GS questionnaires at their bi-annual study follow-up visits until March 2020. Participants were given $15 CAD honoraria for completing each of the 2GS evaluation study questionnaires and $40 CAD for completing each of the parent cohort study questionnaires. Our frontline research staff have employed intensive community-based methods to maintain high follow-up rates, including obtaining contact information for two persons who know the participant and conducting regular outreach to areas frequented by our participants. They have also established/seek to establish rapport with our participants, which has helped minimize some reporting bias such as social desirability bias. Ethics approval for the VIDUS, ACCESS and the 2GS evaluation study was granted by the Providence Health Care/University of British Columbia Research Ethics Board and Simon Fraser University Research Ethics Board.

For the present analyses, we restricted our sample to the VIDUS or ACCESS participants who completed at least one 2GS evaluation study questionnaire and the matched parent cohort study questionnaire between December 2017 and March 2020 and reported having had a health issue that required medical attention in the past six months. Figure 1 delineates how the analytic sample was derived.

Figure 1:

Figure 1:

Determination of the analytic sample.

ACCESS: the AIDS Care Cohort to evaluate Exposure to Survival Services. VIDUS: the Vancouver Injection Drug Users Study. 2GS: Second Generation Strategy.

Study measures

Our primary outcome measure was utilizing healthcare access support in the past six months and derived by asking participants if anyone helped them access the care they needed for their health issues. The “help” was further described as: help making referrals to healthcare providers, help making appointments, and accompaniment to the hospital or clinic. Participants who responded “yes” to the question were further asked who provided them with healthcare access supports, with categories described as follows: family member or friend; peer navigator; outreach worker; healthcare professional; and other (description box provided). We renamed and combined the categories to better reflect where the funding for these supports were coming from. “Informal supports” were defined as help from informal supporters and professionals (excluding healthcare professionals), mostly including friends and family but also a small number (n=6) of reports of police officers, parole officers, etc. This category reflects help received from those who are not specifically paid to render this service.

As both peer navigators (i.e., individuals with lived experience) and outreach workers (i.e., people trained to help marginalized populations) help their clients/peers access healthcare and are paid positions, and outreach workers can be with lived experience, we combined them into a category called “outreach worker”. Indeed, the distinction between the two roles was not highlighted during our surveys. Accordingly, among 361 reports of outreach workers (the combined category), there were only 12 reports of peer navigators. This indicated that some peer navigators might have been reported as outreach workers because peer navigators often conduct outreach. Also, these descriptors were not associated with any specific treatment programs, or we did not ask our participants which programs the outreach workers and/or peer navigators were affiliated with because our study aim was to characterize the utilization of healthcare access supports more generally and not to evaluate every single program of care separately.

Healthcare professionals remained unchanged and reflected those who are highly trained and may often find themselves offering this kind of support when working with systematically marginalised populations but whose job description may not formally include these services. While we did not provide a specific definition of healthcare professionals to our study participants, they usually referred to medical professionals (e.g., doctors, nurses) who work in a clinic or hospital. Some participants also provided their answers in open-text format under the “other” category, which were recategorized by the authors (GR, KH, SK and BN) into either one of the new categories or no help received.

We selected explanatory variables thought to effect availability and utilization of healthcare access supports by considering Anderson’s behavioural model of health service use,33 clinical experience by the authors (GR and SK), and previous work on this dataset.13 Predisposing factors included: age (continuous per year older), self-identified gender (men vs women, transgender, non-binary and other), ethnicity/ancestry (white vs Indigenous or people of colour), educational attainment (less than high school diploma vs completed high school diploma or more), current relationship status (legally married, regular partner living together, or regular partner not living together vs all other responses), homelessness, DTES residency and employment. An enabling factor was attachment to primary care, defined as having a family physician or clinic that they feel comfortable going to as used in a previous study.13 Need-based variables included: drug use patterns (i.e., ≥daily non-prescribed use of opioids, ≥daily use of stimulants [i.e., cocaine, crack cocaine, or crystal methamphetamine], ≥daily alcohol use, having experienced non-fatal overdose and enrolment in a drug or alcohol treatment program), having experienced physical violence, avoidance of healthcare due to the past poor treatment,34 self-reporting unmet healthcare need,13 incarceration, and chronic health conditions (i.e., anxiety symptoms derived from the Patient-Reported Outcome Measurement Information System [PROMIS] short-form anxiety score [moderate to severe vs mild to none],35 chronic pain, defined as reporting pain that has persisted for greater than three months,36 HIV status [positive vs negative], and self-reported HCV status [positive vs negative or unknown]). Because the analytic sample consisted of people who used substances, we considered the following variables as potential co-morbidities beyond substance use: anxiety symptoms, chronic pain, and HIV/HCV seropositivity. All behavioural variables referred to the past six months and were dichotomized as yes vs. no unless otherwise stated.

Statistical analysis

Baseline characteristics of participants stratified by receiving any help accessing healthcare vs no help received were examined using the Pearson’s Chi-square test for categorical variables and the Wilcoxon rank sum test for continuous variables.

Univariable and multivariable generalized linear mixed-effects models under a binomial family with logit link were used to identify factors associated with utilizing healthcare access supports, using all eligible observations, which included multiple observations per person. Any missing observations were treated as missing. We fit four models, including one comparing utilizing any healthcare access supports vs. no supports, and the other three comparing each of the three types of supports vs. no supports. We first fit univariable models for each explanatory variable and each of the four outcome variables, respectively. We did not make any corrections to alpha in the univariable analyses because our modeling approach was exploratory. Then, in all four models, explanatory variables were included in the multivariable analysis if they were associated with the outcome at the p<0.10 level in the univariable analysis. We employed this modeling approach to avoid overloading independent variables. However, as sensitivity analyses, we also fit four multivariable models that included all 22 explanatory variables regardless of their associations with the outcomes in univariable analyses. All p-values were two-sided. Analysis was conducted using SAS version 9.4. We filled out the STROBE check list in the online supplement.

RESULTS

Of the 1001 VIDUS/ACCESS participants who completed at least one 2GS evaluation study questionnaire between December 2017 and March 2020, 996 (99.5%) reported having had a health issue that they felt required medical attention in the past six months and were eligible to participate in the present analysis. The median number of interviews completed per person during the study period was 3 (1st, 3rd quartiles: 2, 4). Table 1 presents the baseline characteristics of the sample. As shown, eight variables had ≤2.5% of missing observations while the anxiety variable had 8.5%. At baseline, 595 (59.9%) participants self-identified as men and the median age was 50 (1st, 3rd quartiles: 41, 57) years. In total, 350 (35.1%) reported receiving healthcare access supports in the past six months, including 62 (6.2%) accessing informal supports, 140 (14.1%) accessing outreach workers, and 208 (20.9%) accessing healthcare professionals. The prevalence of reporting unmet healthcare needs at baseline was not significantly different between those who did and did not receive any supports (27.1% vs. 23.2%, p=0.170). The prevalence among those who accessed informal supports was 25.8%, while it was 26.4% among those accessing outreach workers and 27.4% among those accessing healthcare professionals.

Table 1.

Baseline sample characteristics stratified by utilizing healthcare access supports amongst people who use drugs in Vancouver, British Columbia, Canada between December 2017 and March 2020 (n=996)

Characteristic Total
(n = 996)
N (%)
Utilized healthcare access
supports*
p - value
Yes (35%)
(n = 350)
N (%)
No (65%)
(n = 646)
N (%)
Predisposing factors:
Age (med, 1st to 3rd quartile) 50 (41-57) 49 (41-56) 51 (40-57) 0.062
Ethnicity/ancestry (white vs BIPOC) 531 (54.5%) 161 (46.4%) 345 (55.0%) 0.670
Gender* (men vs women/other) 595 (59.9%) 185 (53.0%) 410 (63.6%) 0.001
Educational attainment (< high school vs ≥ high school completion) †† 464 (47.8%) 165 (48.0%) 299 (47.7%) 0.934
Current relationship status (Legally married/common law/regular partner vs other) 328 (33.0%) 122 (35.0%) 206 (32.0%) 0.342
Homeless* 149 (15.0%) 44 (12.6%) 105 (16.3%) 0.120
DTES residence* 676 (67.9%) 229 (65.4%) 447 (69.2%) 0.224
Employment* 284 (28.5%) 96 (27.4%) 188 (29.1%) 0.577
Enabling factors:
Attachment to primary care* 827 (83.2%) 314 (89.7%) 513 (79.7%) <0.001
Need-based factors:
≥ daily unregulated opioid use* 310 (31.1%) 112 (32.0%) 198 (30.7%) 0.661
≥ daily unregulated stimulant use* 254 (25.5%) 97 (27.7%) 157 (24.3%) 0.238
≥ daily alcohol use* 98 (9.8%) 30 (8.6%) 68 (10.5%) 0.323
Non-fatal overdose* 116 (11.7%) 49 (14.0%) 67 (10.4%) 0.088
Drug or alcohol treatment* 582 (58.4%) 223 (63.7%) 359 (55.6%) 0.013
Experienced physical violence* 85 (8.6%) 39 (11.2%) 46 (7.1%) 0.029
Delaying/avoiding healthcare due to the past poor treatment* 218 (21.9%) 86 (24.6%) 132 (20.4%) 0.132
Self-reporting unmet healthcare need* 245 (24.6%) 95 (27.1%) 150 (23.2%) 0.170
Incarceration* 32 (3.2%) 13 (3.7%) 19 (2.9%) 0.509
PROMIS-SF anxiety score (moderate to severe vs mild to none) ††† 226 (24.8%) 84 (26.6%) 142 (23.9%) 0.366
Chronic pain* 488 (49.1%) 196 (56.0%) 292 (45.3%) 0.001
HIV serostatus (positive vs negative) 404 (40.6%) 172 (49.1%) 232 (35.9%) <0.001
HCV status (positive vs negative/unknown) 828 (83.8%) 301 (86.3%) 527 (82.5%) 0.124

BIPOC: Black, Indigenous or person of color. DTES: Downtown Eastside. PROMIS-SF: Patient-Reported Outcome Measurement Information System short form.

*

denotes behaviour or events occurring in the six months prior to interview.

denotes missing observations 0.1-0.8%

††

missing observations 2.5%

†††

missing observations 8.5%

In multivariable analyses (Table 2 and Figure 2), attachment to primary care (adjusted odds ratio [AOR]=2.35, 95% confidence interval [CI] 1.70-3.25), avoiding seeing healthcare due to poor treatment (AOR=1.44, 95% CI 1.11-1.86), chronic pain (AOR=1.42, 95% CI 1.18-1.73), and living with HIV (AOR=1.82, 95% CI 1.48-2.24) were all independently and positively associated with utilizing any supports. Conversely, older age (per year older) was negatively associated with utilizing any supports (AOR=0.97, 95% CI 0.96-0.99). Men were also negatively associated with utilizing any supports (AOR=0.58, 95% CI 0.47-0.72).

Table 2.

Univariable and multivariable generalized linear mixed-effects model identifying factors associated with utilizing each of the three types of healthcare access supports amongst people who use drugs in Vancouver, Canada from December 2017 to March 2020 (n=2976).

Variable Utilized any help
(n=807)
Informal supports
(n=124)
Outreach workers
(n=361)
Healthcare professionals
(n=408)
vs. Did not utilize any help (n=2169)
OR
(95% CI)
AOR
(95% CI)
OR
(95% CI)
AOR
(95% CI)
OR
(95% CI)
AOR
(95% CI)
OR
(95% CI)
AOR
(95% CI)
Predisposing factors:
Age
 (per year older)
0.98††
(0.97-0.99)
0.97††
(0.96-0.99)
0.97††
(0.95-0.99)
0.98
(0.96-1.10)
0.95††
(0.94-0.97)
0.96††
(0.94-0.98)
0.99
(0.98-1.00)
Ethnicity/ancestry
 (white vs BIPOC)
1.25
(1.02-1.55)
0.96
(0.78-1.18)
2.16††
(1.39-3.35)
1.58
(0.98-2.55)
1.66††
(1.14-2.40)
1.09
(0.77-1.54)
1.05
(0.84-1.33)
Gender*
 (men vs women/other)
0.49††
(0.40-0.61)
0.58††
(0.47-0.72)
0.33††
(0.21-0.51)
0.46††
(0.28-0.75)
0.33††
(0.23-0.47)
0.46††
(0.33-0.65)
0.66††
(0.53-0.83)
0.68††
(0.55-0.85)
Educational attainment
 (<high school vs ≥high school diploma)
0.88
(0.71-1.08)
0.52††
(0.33-0.80)
0.61
(0.38-0.97)
0.76
(0.53-1.10)
1.01
(0.81-1.28)
Current relationship status
 (Legally married/common law/regular partner vs other)
1.20
(0.97-1.49)
1.04
(0.84-1.28)
2.15
(1.14-4.05)
1.87
(0.99-3.53)
0.96
(0.66-1.39)
0.97
(0.76-1.24)
Homeless*
 (yes vs. no)
0.93
(0.69-1.26)
0.36
(0.06-2.20)
1.16
(0.72-1.88)
0.87
(0.61-1.24)
Resides in the DTES*
 (yes vs. no)
1.08
(0.87-1.33)
0.52
(0.24-1.14)
1.88††
(1.30-2.72)
1.69††
(1.18-2.44)
1.02
(0.80-1.29)
Employment*
 (yes vs no)
0.79
(0.64-0.99)
0.90
(0.73-1.12)
0.67
(0.25-1.79)
0.62††
(0.43-0.88)
0.72
(0.51-1.03)
0.93
(0.72-1.20)
Enabling factors:
Attachment to primary care*
 (yes vs. no)
2.01††
(1.49-2.70)
2.35††
(1.70-3.25)
1.36
(0.49-3.83)
1.55
(0.97-2.47)
1.70
(1.04-2.79)
2.50††
(1.67-3.75)
3.07††
(1.97-4.80)
Need-based factors:
Unregulated opioid use*
 (≥ daily vs < daily)
1.12
(0.90-1.38)
1.26
(0.56-2.85)
1.34
(0.95-1.88)
0.94
(0.67-1.33)
0.94
(0.74-1.21)
Unregulated stimulant use*
 (≥ daily vs < daily)
1.15
(0.93-1.41)
1.69
(0.77-3.68)
1.42
(1.00-2.02)
1.32
(0.95-1.84)
1.04
(0.81-1.33)
Alcohol use*
 (≥ daily vs < daily)
0.82
(0.60-1.13)
1.42
(0.51-3.98)
0.58
(0.33-1.02)
0.56
(0.31-1.00)
0.92
(0.64-1.31)
Non-fatal overdose*
 (yes vs no)
1.06
(0.82-1.38)
0.60
(0.16-2.31)
1.18
(0.78-1.79)
1.06
(0.78-1.45)
Drug or alcohol treatment*
 (yes vs no)
1.34††
(1.10-1.64)
1.19
(0.98-1.46)
1.18
(0.56-2.53)
1.60††
(1.16-2.22)
1.56††
(1.12-2.18)
1.15
(0.92-1.45)
Experienced physical violence*
 (yes vs no)
1.50
(1.07-2.11)
1.34
(0.94-1.90)
1.56
(0.43-5.61)
1.95††
(1.17-3.25)
1.43
(0.83-2.45)
1.22
(0.81-1.85)
Delaying/avoiding healthcare due to the past poor treatment*
 (yes vs no)
1.40††
(1.11-1.78)
1.44††
(1.11-1.86)
1.66
(0.70-3.94)
1.51
(1.04-2.19)
1.53
(1.04-2.25)
1.39
(1.04-1.85)
1.51††
(1.11-2.04)
Self-reporting unmet healthcare need*
 (yes vs. no)
1.24
(0.99-1.56)
1.20
(0.94-1.55)
1.56
(0.67-3.64)
1.19
(0.82-1.73)
1.26
(0.96-1.64)
1.33
(0.99-1.79)
Incarceration*
 (yes vs no)
1.10
(0.59-1.73)
1.43
(0.23-8.76)
1.06
(0.48-2.33)
0.68
(0.32-1.44)
PROMIS-SF anxiety score
 (moderate to severe vs mild to none)
1.15
(0.93-1.42)
0.60
(0.18-2.01)
1.74††
(1.24-2.44)
1.42
(1.01-1.99)
0.95
(0.73-1.23)
Chronic pain*
 (yes vs no)
1.51††
(1.24-1.82)
1.42††
(1.18-1.73)
1.46
(0.72-2.93)
1.39
(1.02-1.90)
1.39
(1.02-1.89)
1.57††
(1.26-1.97)
1.46††
(1.17-1.83)
HIV serostatus
 (positive vs negative)
1.79††
(1.45-2.21)
1.82††
(1.48-2.24)
0.83
(0.53-1.29)
3.21††
(2.22-4.64)
3.69††
(2.57-5.29)
1.51††
(1.20-1.90)
1.45††
(1.16-1.81)
HCV status
 (positive vs. negative or unknown)
1.30
(0.97-1.74)
1.29
(0.96-1.72)
1.19
(0.65-2.16)
1.31
(0.79-2.18)
1.40
(1.02-1.93)
1.32
(0.97-1.80)

AOR: adjusted odds ratio. BIPOC: Black, Indigenous or person of color. CI: confidence interval. DTES: Downtown Eastside. HCV: hepatitis C virus. OR: odds ratio. PROMIS-SF: Patient-Reported Outcome Measurement Information System short form.

*

denotes behaviour or events occurring in the six months prior to interview.

denotes p<0.05

††

denotes p<0.01.

Figure 2:

Figure 2:

Forest plots of the multivariable analyses results.

As for the support-type specific independent associations, as shown in Table 2, attachment to primary care, avoiding seeking healthcare due to the past poor treatment, chronic pain and living with HIV were all positively associated with utilizing outreach workers and healthcare professionals, respectively, but not with informal supports. Living in the DTES, drug or alcohol treatment and moderate/severe anxiety symptomology, and younger age were significantly associated with utilizing outreach worker supports only, while having an education level of less than high school diploma was negatively associated with accessing informal supports only. The results of the sensitivity analyses are shown in Supplement Table 1. As shown, the factors that remained significantly associated with utilizing any supports were identical with those found the primary analyses. The support-type specific independent associations were also almost identical with a few exceptions.

DISCUSSION

Amongst a cohort of 996 PWUD, 35% endorsed utilizing healthcare access supports in the past six months at baseline. Those who received supports were more likely to report attachment to primary care, avoidance in seeking healthcare due to the past mistreatment, chronic pain and living with HIV. Those who sought and received support from healthcare professionals had similar characteristics as those who utilized health care access supports in general. In addition to the aforementioned factors, those accessing outreach workers were more likely to live in the DTES, be enrolled in drug or alcohol treatment, and have moderate to severe symptoms of anxiety. Those who received help from informal supports were more likely to have completed high school and men were less likely to receive any forms of support.

We are not aware of any previous work characterizing the use of different types of healthcare access supports amongst PWUD in real-world settings. We found that those who received healthcare access supports were generally characterized by increased comorbidities—including chronic pain and HIV seropositivity—compared to those who did not. This difference may be partially explained by the disease-specific targeted supports available in our study setting, such as the STOP HIV/AIDS team for those living with HIV27 and the ACT team for active psychiatric disorders.26 Despite the high comorbidities and the finding that they were more likely to report avoiding seeking healthcare due to the past poor treatment, this group of PWUD were not necessarily more likely to report unmet healthcare needs, which is encouraging as it may imply that the healthcare access supports may be filling the important gap. However, disease specific supports unlikely address the full range of comorbidities experienced by those who accessed supports. For example, those with chronic pain do not have access to disease specific supports in our study setting. In fact, we also found that suffering from chronic pain and avoiding healthcare were both associated with accessing formal supports. Chronic pain is estimated to effect one in four adult Canadians and cost the economy an estimated $40.4 billion in 2019 alone.37 Misunderstanding of pain in relation to addiction is prevalent38 and physicians are often reluctant to prescribe opioid analgesics to PWUD for fear of diversion,39 often denying it altogether.40,41 Even amongst providers experienced in treating comorbid chronic pain and substance use, their clinical practices vary widely.42 In our previous study, chronic pain was associated with unmet healthcare needs.13 More work needs to be done to address chronic pain and other comorbidities commonly experienced by PWUD.

The relatively low utilization of formal supports (i.e., healthcare professionals or outreach workers) observed across our study sample (35%) despite the high levels of co-morbidities and structural marginalization may be partially explained by the inadequate availability of formal supports in our study setting. In a study of homeless youth in Alberta, Canada, 80% utilized targeted peer and professional supports.43 While our results cannot directly be compared to this pilot intervention, given that 68% of our study sample resided in the DTES at baseline where the DTES-2GS established integrated care clinics that involved outreach workers and put an emphasis on better coordinated care,28 one may expect higher coverage of formal supports. In particular, our findings that men were less likely to utilize any supports accessing healthcare indicate that more targeted outreach efforts are needed for men who use drugs. Further, the finding that 23% of those who did not receive any support reported unmet healthcare needs at baseline indicates that more could be done for this sub-population as well, and some may benefit from increased access to formal health accesses supports such as outreach workers. Increasing the coverage of formal supports is also important given that informal supports would impose a substantial burden on families and peers.

Our results also indicated that PWUD receiving supports from outreach workers and peer navigators may have had the highest burden of disease (e.g., moderate to high anxiety symptomology, HIV, and chronic pain) and were also more likely to avoid accessing care due to poor treatment in the past. Yet, there was no significant association between unmet healthcare needs and receiving supports from outreach workers. These findings suggests that outreach workers might have played an important role in alleviating some of the unmet healthcare needs for this high priority sub-population of PWUD. A large body of literature demonstrates the multitudes of health and social benefits outreach workers and peer navigators can offer in disease and situation-specific situations as well as in randomized control trials.4,10,16-25,44 Our study advances the knowledge in this field by characterizing the utilization of outreach workers’ services among a large sample of PWUD in a real-world setting where structural changes in the primary care system have been implemented (i.e., DTES-2GS). More research needs to be done to quantify the benefit outreach workers and peers provide to PWUD clients to identify gaps in coverage and advocate for increased support for these vital services. Also, as peer workers tend to be exploited, particularly but not limited to in community-based harm reduction service sites,45 there is a need to ensure that peer navigators be adequately compensated and supported for the important work they provide.

There are some limitations to this study. First, the study sample was not randomly recruited, and therefore might not necessarily be generalizable to all PWUD in Vancouver. Second, many of the variables were self-reported, which may contribute to reporting bias. Third, because our study aim was to characterize the overall utilization of different types of healthcare supports in our study setting, we did not ask our participants which specific programs the help (e.g., outreach workers) was associated with. This limits our ability to evaluate the effects of each specific program such as ACT teams. Lastly, as the majority of the explanatory variables used the same time frame (i.e., in the past six months) with the outcome variables, we are unable to establish the temporal sequence between the explanatory and outcome variables.

Conclusion

In sum, we found that 35% of our sample of PWUD in Vancouver received some forms of support when they accessed healthcare at baseline between December 2017 and March 2020. The relatively low utilization of formal supports (i.e., healthcare professionals or outreach workers) despite the high levels of co-morbidities and structural marginalization indicated the need to enhance the availability of formal supports. While we identified heterogenous characteristics of PWUD across different types of healthcare support utilized, receiving formal supports was associated with higher comorbidities, including HIV and chronic pain. Further efforts to make formal supports more available would benefit PWUD with unmet healthcare need, particularly men.

Supplementary Material

supplementary material

Acknowledgments

The VIDUS and ACCESS studies take place on the unceded territory of the Coast Salish Peoples, including the territories of the xwməθkwəy’əm (Musqueam), Skwxwú7mesh (Squamish), Stó:lō and Səl’ílwətaʔ/Selilwitulh (Tsleil-Waututh) Nations. The authors would like to thank the study participants as well as current and past researchers and staff; their time and efforts have been an invaluable contribution to this research.

Funding

This study is supported by the Canadian Institutes of Health Research (CIHR; PJT-15924) and National Institutes of Health (NIH; U01DA038886, U01DA021525). KH holds the St. Paul’s Hospital Chair in Substance Use Research and is supported in part by the NIH (U01DA038886), a Michael Smith Health Research BC Scholar Award, and the St. Paul’s Foundation. GR is supported by the NIH-funded International Collaborative Addiction Medicine Research Fellowship (R25-DA037756). BN holds a St. Paul's Hospital CANFAR Chair in HIV/AIDS Research. MJM is supported by the US NIH (U01-DA0251525).

Footnotes

Disclosure Statement

MJM is the Canopy Growth professor of cannabis science at the University of British Columbia, a position established through arms' length gifts to the university from Canopy Growth Corporation, a licensed producer of cannabis in Canada, and the Government of British Columbia's Ministry of Mental Health and Addictions. He has no personal financial relationships to the cannabis industry. The other authors report no potential conflict of interest.

REFERENCES

  • 1.Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70. doi: 10.1016/S0140-6736(11)61138-0 [DOI] [PubMed] [Google Scholar]
  • 2.Walker ER, Pratt LA, Schoenborn CA, Druss BG. Excess mortality among people who report lifetime use of illegal drugs in the United States: A 20-year follow-up of a nationally representative survey. Drug Alcohol Depend. 2017;171:31–38. doi: 10.1016/j.drugalcdep.2016.11.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Murthy VH. Facing Addiction in the United States: The Surgeon General’s Report of Alcohol, Drugs, and Health. JAMA. 2017;317(2):133. doi: 10.1001/jama.2016.18215 [DOI] [PubMed] [Google Scholar]
  • 4.Luchenski S, Maguire N, Aldridge RW, et al. What works in inclusion health: overview of effective interventions for marginalised and excluded populations. Lancet. 2018;391(10117):266–280. doi: 10.1016/S0140-6736(17)31959-1 [DOI] [PubMed] [Google Scholar]
  • 5.Chitwood DD, McBRIDE DC, Metsch LR, Comerford M, McCOY CB. A comparison of the need for health care and use of health care by injection-drug users, other chronic drug users, and nondrug users. Am Behav Sci. 1998;41(8):1107–1122. doi: 10.1177/0002764298041008007 [DOI] [Google Scholar]
  • 6.Day C, Ross J, Dolan K. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev. 2003;22(3):317–321. doi: 10.1080/0959523031000154463 [DOI] [PubMed] [Google Scholar]
  • 7.Islam MM. Needle syringe program-based primary healthcare centers: advantages and disadvantages. J Prim Care Community Health. 2010;1(2):100–103. doi: 10.1177/2150131910369684 [DOI] [PubMed] [Google Scholar]
  • 8.Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94–102. doi: 10.1016/j.drugpo.2011.08.005 [DOI] [PubMed] [Google Scholar]
  • 9.Rowe J. Needles and syringes to care and counselling: The need for innovative primary health care to meet the needs of street-based injecting drug users. Aust J Prim Health. 2004;10(1):49. doi: 10.1071/PY04007 [DOI] [Google Scholar]
  • 10.Brener L, von Hippel W, von Hippel C, Resnick I, Treloar C. Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev. 2010;29(5):491–497. doi: 10.1111/j.1465-3362.2010.00173.x [DOI] [PubMed] [Google Scholar]
  • 11.McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6-7):789–806. doi: 10.1081/ja-100104091 [DOI] [PubMed] [Google Scholar]
  • 12.French MT, McGeary KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med. 2000;50(12):1703–1713. doi: 10.1016/s0277-9536(99)00411-6 [DOI] [PubMed] [Google Scholar]
  • 13.Moallef S, Homayra F, Milloy MJ, Bird L, Nosyk B, Hayashi K. High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics. Subst Abuse. 2021;42(4):760–766. doi: 10.1080/08897077.2020.1846667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hyshka E, Anderson JT, Wild TC. Perceived unmet need and barriers to care amongst street-involved people who use illicit drugs. Drug Alcohol Rev. 2017;36(3):295–304. doi: 10.1111/dar.12427 [DOI] [PubMed] [Google Scholar]
  • 15.Dennis CL. Peer support within a health care context: a concept analysis. Int J Nurs Stud. 2003;40(3):321–332. doi: 10.1016/s0020-7489(02)00092-5 [DOI] [PubMed] [Google Scholar]
  • 16.Barker SL, Maguire N. Experts by experience: peer support and its use with the homeless. Community Ment Health J. 2017;53(5):598–612. doi: 10.1007/s10597-017-0102-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Felton CJ, Stastny P, Shern DL, et al. Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv. 1995;46(10):1037–1044. doi: 10.1176/ps.46.10.1037 [DOI] [PubMed] [Google Scholar]
  • 18.Kouyoumdjian FG, McIsaac KE, Liauw J, et al. A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after release. Am J Public Health. 2015;105(4):e13–33. doi: 10.2105/AJPH.2014.302498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bagnall AM, South J, Hulme C, et al. A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons. BMC Public Health. 2015;15:290. doi: 10.1186/s12889-015-1584-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tracy K, Wachtel L, Goldmann E, et al. Mentorship for Addiction Problems (MAP): A new behavioral intervention to assist in the treatment of substance use disorders. J Stud Alcohol Drugs. 2020;81(5):664–672. doi: 10.15288/jsad.2020.81.664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Boisvert RA, Martin LM, Grosek M, Clarie AJ. Effectiveness of a peer-support community in addiction recovery: participation as intervention. Occup Ther Int. 2008;15(4):205–220. doi: 10.1002/oti.257 [DOI] [PubMed] [Google Scholar]
  • 22.Parent N, Fortin F. A randomized, controlled trial of vicarious experience through peer support for male first-time cardiac surgery patients: impact on anxiety, self-efficacy expectation, and self-reported activity. Heart Lung J Crit Care. 2000;29(6):389–400. doi: 10.1067/mhl.2000.110626 [DOI] [PubMed] [Google Scholar]
  • 23.Wilson W, Pratt C. The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with noninsulin dependent diabetes mellitus (NIDDM). Am J Public Health. 1987;77(5):634–635. doi: 10.2105/ajph.77.5.634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hoey LM, Ieropoli SC, White VM, Jefford M. Systematic review of peer-support programs for people with cancer. Patient Educ Couns. 2008;70(3):315–337. doi: 10.1016/j.pec.2007.11.016 [DOI] [PubMed] [Google Scholar]
  • 25.Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46(2):238–244. doi: 10.1097/QAI.0b013e318153f7ba [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.British Columbia Advanced Practice. Assertive Community Treatment (ACT) in BC. Accessed May 2, 2023. https://act-bc.ca
  • 27.Seek and Treat for Optimal Prevention of HIV/AIDS: STOP HIV/AIDS. Accessed May 2, 2023. https://stophivaids.ca
  • 28.Vancouver Coastal Health Authority. Downtown Eastside 2nd Generation Strategy. Published November 22, 2022. Accessed May 2, 2023. https://www.vch.ca/en/downtown-eastside-2nd-generation-strategy
  • 29.Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the Vancouver Downtown Eastside from 2001 to 2011. J Urban Health. 2013;90(3):559–573. doi: 10.1007/s11524-012-9771-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Vancouver Coastal Health Authority. Peer Framework for Health-Focused Peer Positions in the Downtown Eastside.; 2015. Accessed May 2, 2023. https://www.vch.ca/sites/default/files/import/documents/DTES-Peer-Framework.pdf
  • 31.Olding M, Hayashi K, Pearce L, et al. Developing a patient-reported experience questionnaire with and for people who use drugs: A community engagement process in Vancouver’s Downtown Eastside. Int J Drug Policy. 2018;59:16–23. doi: 10.1016/j.drugpo.2018.06.003 [DOI] [PubMed] [Google Scholar]
  • 32.Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649. doi: 10.1136/bmj.b1649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s behavioral model of health services use: a systematic review of studies from 1998-2011. Psycho-Soc Med. 2012;9:Doc11. doi: 10.3205/psm000089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Moallef S, Dale L, Homayra F, et al. Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform. J Subst Abuse Treat. 2022;139:108784. doi: 10.1016/j.jsat.2022.108784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB. Advances in patient-reported outcomes: The NIH PROMIS(®) measures. EGEMS Wash DC. 2013;1(1):1015. doi: 10.13063/2327-9214.1015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986;3:S1–226. [PubMed] [Google Scholar]
  • 37.Canadian Pain Task Force. Working Together to Better Understand, Prevent, and Manage Chronic Pain: What We Heard. Health Canada; 2020. Accessed May 2, 2023. https://www.canada.ca/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/canadian-pain-task-force/report-2020.html (2020) [Google Scholar]
  • 38.Lebovits AH, Florence I, Bathina R, Hunko V, Fox MT, Bramble CY. Pain knowledge and attitudes of healthcare providers: practice characteristic differences. Clin J Pain. 1997;13(3):237–243. doi: 10.1097/00002508-199709000-00009 [DOI] [PubMed] [Google Scholar]
  • 39.Baldacchino A, Gilchrist G, Fleming R, Bannister J. Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav. 2010;35(3):270–272. doi: 10.1016/j.addbeh.2009.10.008 [DOI] [PubMed] [Google Scholar]
  • 40.Fibbi M, Silva K, Johnson K, Langer D, Lankenau SE. Denial of prescription opioids among young adults with histories of opioid misuse. Pain Med. 2012;13(8):1040–1048. doi: 10.1111/j.1526-4637.2012.01439.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Voon P, Callon C, Nguyen P, et al. Denial of prescription analgesia among people who inject drugs in a Canadian setting. Drug Alcohol Rev. 2015;34(2):221–228. doi: 10.1111/dar.12226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers’ experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24(4):482–488. doi: 10.1007/s11606-009-0908-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Stewart M, Reutter L, Letourneau N, Makwarimba E. A support intervention to promote health and coping among homeless youths. Can J Nurs Res Rev Can Rech En Sci Infirm. 2009;41(2):55–77. [PubMed] [Google Scholar]
  • 44.Crawford S, Bath N. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection. Clin Infect Dis. 2013;57(suppl 2):S75–S79. doi: 10.1093/cid/cit297 [DOI] [PubMed] [Google Scholar]
  • 45.Olding M, Barker A, McNeil R, Boyd J. Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19. Int J Drug Policy. 2021;90:103076. doi: 10.1016/j.drugpo.2020.103076 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplementary material

RESOURCES